Antibody Drug Conjugate Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Antibody Drug Conjugate in global, including the following market information:
Global Antibody Drug Conjugate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antibody Drug Conjugate Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antibody Drug Conjugate companies in 2021 (%)
The global Antibody Drug Conjugate market was valued at 1746 million in 2021 and is projected to reach US$ 2803.7 million by 2028, at a CAGR of 7.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adcetris Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antibody Drug Conjugate include Seattle Genetics/Takeda, Roche, ImmunoGen, Immunomedics, Pfizer, Celldex Therapeutics, Millennium Pharmaceuticals, Bayer HealthCare and Mersana Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody Drug Conjugate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibody Drug Conjugate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibody Drug Conjugate Market Segment Percentages, by Type, 2021 (%)
Global Antibody Drug Conjugate Market Segment Percentages, by Application, 2021 (%)
Global Antibody Drug Conjugate Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Antibody Drug Conjugate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antibody Drug Conjugate revenues share in global market, 2021 (%)
Key companies Antibody Drug Conjugate sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antibody Drug Conjugate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Antibody Drug Conjugate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antibody Drug Conjugate Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antibody Drug Conjugate companies in 2021 (%)
The global Antibody Drug Conjugate market was valued at 1746 million in 2021 and is projected to reach US$ 2803.7 million by 2028, at a CAGR of 7.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adcetris Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antibody Drug Conjugate include Seattle Genetics/Takeda, Roche, ImmunoGen, Immunomedics, Pfizer, Celldex Therapeutics, Millennium Pharmaceuticals, Bayer HealthCare and Mersana Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody Drug Conjugate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibody Drug Conjugate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibody Drug Conjugate Market Segment Percentages, by Type, 2021 (%)
- Adcetris
- Kadcyl
- Other
Global Antibody Drug Conjugate Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Pharmaceutical Company
- Research Institutions
Global Antibody Drug Conjugate Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Antibody Drug Conjugate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antibody Drug Conjugate revenues share in global market, 2021 (%)
Key companies Antibody Drug Conjugate sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antibody Drug Conjugate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Seattle Genetics/Takeda
- Roche
- ImmunoGen
- Immunomedics
- Pfizer
- Celldex Therapeutics
- Millennium Pharmaceuticals
- Bayer HealthCare
- Mersana Therapeutics
- Heidelberg Pharma
- Oxford BioTherapeutics
- Takeda Pharmaceutical Company Limited
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Antibody Drug Conjugate Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antibody Drug Conjugate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIBODY DRUG CONJUGATE OVERALL MARKET SIZE
2.1 Global Antibody Drug Conjugate Market Size: 2021 VS 2028
2.2 Global Antibody Drug Conjugate Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antibody Drug Conjugate Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antibody Drug Conjugate Players in Global Market
3.2 Top Global Antibody Drug Conjugate Companies Ranked by Revenue
3.3 Global Antibody Drug Conjugate Revenue by Companies
3.4 Global Antibody Drug Conjugate Sales by Companies
3.5 Global Antibody Drug Conjugate Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antibody Drug Conjugate Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antibody Drug Conjugate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibody Drug Conjugate Players in Global Market
3.8.1 List of Global Tier 1 Antibody Drug Conjugate Companies
3.8.2 List of Global Tier 2 and Tier 3 Antibody Drug Conjugate Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antibody Drug Conjugate Market Size Markets, 2021 & 2028
4.1.2 Adcetris
4.1.3 Kadcyl
4.1.4 Other
4.2 By Type - Global Antibody Drug Conjugate Revenue & Forecasts
4.2.1 By Type - Global Antibody Drug Conjugate Revenue, 2017-2022
4.2.2 By Type - Global Antibody Drug Conjugate Revenue, 2023-2028
4.2.3 By Type - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
4.3 By Type - Global Antibody Drug Conjugate Sales & Forecasts
4.3.1 By Type - Global Antibody Drug Conjugate Sales, 2017-2022
4.3.2 By Type - Global Antibody Drug Conjugate Sales, 2023-2028
4.3.3 By Type - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
4.4 By Type - Global Antibody Drug Conjugate Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antibody Drug Conjugate Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmaceutical Company
5.1.4 Research Institutions
5.2 By Application - Global Antibody Drug Conjugate Revenue & Forecasts
5.2.1 By Application - Global Antibody Drug Conjugate Revenue, 2017-2022
5.2.2 By Application - Global Antibody Drug Conjugate Revenue, 2023-2028
5.2.3 By Application - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
5.3 By Application - Global Antibody Drug Conjugate Sales & Forecasts
5.3.1 By Application - Global Antibody Drug Conjugate Sales, 2017-2022
5.3.2 By Application - Global Antibody Drug Conjugate Sales, 2023-2028
5.3.3 By Application - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
5.4 By Application - Global Antibody Drug Conjugate Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antibody Drug Conjugate Market Size, 2021 & 2028
6.2 By Region - Global Antibody Drug Conjugate Revenue & Forecasts
6.2.1 By Region - Global Antibody Drug Conjugate Revenue, 2017-2022
6.2.2 By Region - Global Antibody Drug Conjugate Revenue, 2023-2028
6.2.3 By Region - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
6.3 By Region - Global Antibody Drug Conjugate Sales & Forecasts
6.3.1 By Region - Global Antibody Drug Conjugate Sales, 2017-2022
6.3.2 By Region - Global Antibody Drug Conjugate Sales, 2023-2028
6.3.3 By Region - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antibody Drug Conjugate Revenue, 2017-2028
6.4.2 By Country - North America Antibody Drug Conjugate Sales, 2017-2028
6.4.3 US Antibody Drug Conjugate Market Size, 2017-2028
6.4.4 Canada Antibody Drug Conjugate Market Size, 2017-2028
6.4.5 Mexico Antibody Drug Conjugate Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antibody Drug Conjugate Revenue, 2017-2028
6.5.2 By Country - Europe Antibody Drug Conjugate Sales, 2017-2028
6.5.3 Germany Antibody Drug Conjugate Market Size, 2017-2028
6.5.4 France Antibody Drug Conjugate Market Size, 2017-2028
6.5.5 U.K. Antibody Drug Conjugate Market Size, 2017-2028
6.5.6 Italy Antibody Drug Conjugate Market Size, 2017-2028
6.5.7 Russia Antibody Drug Conjugate Market Size, 2017-2028
6.5.8 Nordic Countries Antibody Drug Conjugate Market Size, 2017-2028
6.5.9 Benelux Antibody Drug Conjugate Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antibody Drug Conjugate Revenue, 2017-2028
6.6.2 By Region - Asia Antibody Drug Conjugate Sales, 2017-2028
6.6.3 China Antibody Drug Conjugate Market Size, 2017-2028
6.6.4 Japan Antibody Drug Conjugate Market Size, 2017-2028
6.6.5 South Korea Antibody Drug Conjugate Market Size, 2017-2028
6.6.6 Southeast Asia Antibody Drug Conjugate Market Size, 2017-2028
6.6.7 India Antibody Drug Conjugate Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antibody Drug Conjugate Revenue, 2017-2028
6.7.2 By Country - South America Antibody Drug Conjugate Sales, 2017-2028
6.7.3 Brazil Antibody Drug Conjugate Market Size, 2017-2028
6.7.4 Argentina Antibody Drug Conjugate Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antibody Drug Conjugate Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antibody Drug Conjugate Sales, 2017-2028
6.8.3 Turkey Antibody Drug Conjugate Market Size, 2017-2028
6.8.4 Israel Antibody Drug Conjugate Market Size, 2017-2028
6.8.5 Saudi Arabia Antibody Drug Conjugate Market Size, 2017-2028
6.8.6 UAE Antibody Drug Conjugate Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Seattle Genetics/Takeda
7.1.1 Seattle Genetics/Takeda Corporate Summary
7.1.2 Seattle Genetics/Takeda Business Overview
7.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Major Product Offerings
7.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.1.5 Seattle Genetics/Takeda Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Antibody Drug Conjugate Major Product Offerings
7.2.4 Roche Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.2.5 Roche Key News
7.3 ImmunoGen
7.3.1 ImmunoGen Corporate Summary
7.3.2 ImmunoGen Business Overview
7.3.3 ImmunoGen Antibody Drug Conjugate Major Product Offerings
7.3.4 ImmunoGen Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.3.5 ImmunoGen Key News
7.4 Immunomedics
7.4.1 Immunomedics Corporate Summary
7.4.2 Immunomedics Business Overview
7.4.3 Immunomedics Antibody Drug Conjugate Major Product Offerings
7.4.4 Immunomedics Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.4.5 Immunomedics Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Antibody Drug Conjugate Major Product Offerings
7.5.4 Pfizer Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Celldex Therapeutics
7.6.1 Celldex Therapeutics Corporate Summary
7.6.2 Celldex Therapeutics Business Overview
7.6.3 Celldex Therapeutics Antibody Drug Conjugate Major Product Offerings
7.6.4 Celldex Therapeutics Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.6.5 Celldex Therapeutics Key News
7.7 Millennium Pharmaceuticals
7.7.1 Millennium Pharmaceuticals Corporate Summary
7.7.2 Millennium Pharmaceuticals Business Overview
7.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Major Product Offerings
7.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.7.5 Millennium Pharmaceuticals Key News
7.8 Bayer HealthCare
7.8.1 Bayer HealthCare Corporate Summary
7.8.2 Bayer HealthCare Business Overview
7.8.3 Bayer HealthCare Antibody Drug Conjugate Major Product Offerings
7.8.4 Bayer HealthCare Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.8.5 Bayer HealthCare Key News
7.9 Mersana Therapeutics
7.9.1 Mersana Therapeutics Corporate Summary
7.9.2 Mersana Therapeutics Business Overview
7.9.3 Mersana Therapeutics Antibody Drug Conjugate Major Product Offerings
7.9.4 Mersana Therapeutics Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.9.5 Mersana Therapeutics Key News
7.10 Heidelberg Pharma
7.10.1 Heidelberg Pharma Corporate Summary
7.10.2 Heidelberg Pharma Business Overview
7.10.3 Heidelberg Pharma Antibody Drug Conjugate Major Product Offerings
7.10.4 Heidelberg Pharma Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.10.5 Heidelberg Pharma Key News
7.11 Oxford BioTherapeutics
7.11.1 Oxford BioTherapeutics Corporate Summary
7.11.2 Oxford BioTherapeutics Antibody Drug Conjugate Business Overview
7.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Major Product Offerings
7.11.4 Oxford BioTherapeutics Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.11.5 Oxford BioTherapeutics Key News
7.12 Takeda Pharmaceutical Company Limited
7.12.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.12.2 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Business Overview
7.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Major Product Offerings
7.12.4 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.12.5 Takeda Pharmaceutical Company Limited Key News
8 GLOBAL ANTIBODY DRUG CONJUGATE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antibody Drug Conjugate Production Capacity, 2017-2028
8.2 Antibody Drug Conjugate Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibody Drug Conjugate Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIBODY DRUG CONJUGATE SUPPLY CHAIN ANALYSIS
10.1 Antibody Drug Conjugate Industry Value Chain
10.2 Antibody Drug Conjugate Upstream Market
10.3 Antibody Drug Conjugate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antibody Drug Conjugate Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Antibody Drug Conjugate Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antibody Drug Conjugate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIBODY DRUG CONJUGATE OVERALL MARKET SIZE
2.1 Global Antibody Drug Conjugate Market Size: 2021 VS 2028
2.2 Global Antibody Drug Conjugate Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antibody Drug Conjugate Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antibody Drug Conjugate Players in Global Market
3.2 Top Global Antibody Drug Conjugate Companies Ranked by Revenue
3.3 Global Antibody Drug Conjugate Revenue by Companies
3.4 Global Antibody Drug Conjugate Sales by Companies
3.5 Global Antibody Drug Conjugate Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antibody Drug Conjugate Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antibody Drug Conjugate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibody Drug Conjugate Players in Global Market
3.8.1 List of Global Tier 1 Antibody Drug Conjugate Companies
3.8.2 List of Global Tier 2 and Tier 3 Antibody Drug Conjugate Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antibody Drug Conjugate Market Size Markets, 2021 & 2028
4.1.2 Adcetris
4.1.3 Kadcyl
4.1.4 Other
4.2 By Type - Global Antibody Drug Conjugate Revenue & Forecasts
4.2.1 By Type - Global Antibody Drug Conjugate Revenue, 2017-2022
4.2.2 By Type - Global Antibody Drug Conjugate Revenue, 2023-2028
4.2.3 By Type - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
4.3 By Type - Global Antibody Drug Conjugate Sales & Forecasts
4.3.1 By Type - Global Antibody Drug Conjugate Sales, 2017-2022
4.3.2 By Type - Global Antibody Drug Conjugate Sales, 2023-2028
4.3.3 By Type - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
4.4 By Type - Global Antibody Drug Conjugate Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antibody Drug Conjugate Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmaceutical Company
5.1.4 Research Institutions
5.2 By Application - Global Antibody Drug Conjugate Revenue & Forecasts
5.2.1 By Application - Global Antibody Drug Conjugate Revenue, 2017-2022
5.2.2 By Application - Global Antibody Drug Conjugate Revenue, 2023-2028
5.2.3 By Application - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
5.3 By Application - Global Antibody Drug Conjugate Sales & Forecasts
5.3.1 By Application - Global Antibody Drug Conjugate Sales, 2017-2022
5.3.2 By Application - Global Antibody Drug Conjugate Sales, 2023-2028
5.3.3 By Application - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
5.4 By Application - Global Antibody Drug Conjugate Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antibody Drug Conjugate Market Size, 2021 & 2028
6.2 By Region - Global Antibody Drug Conjugate Revenue & Forecasts
6.2.1 By Region - Global Antibody Drug Conjugate Revenue, 2017-2022
6.2.2 By Region - Global Antibody Drug Conjugate Revenue, 2023-2028
6.2.3 By Region - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
6.3 By Region - Global Antibody Drug Conjugate Sales & Forecasts
6.3.1 By Region - Global Antibody Drug Conjugate Sales, 2017-2022
6.3.2 By Region - Global Antibody Drug Conjugate Sales, 2023-2028
6.3.3 By Region - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antibody Drug Conjugate Revenue, 2017-2028
6.4.2 By Country - North America Antibody Drug Conjugate Sales, 2017-2028
6.4.3 US Antibody Drug Conjugate Market Size, 2017-2028
6.4.4 Canada Antibody Drug Conjugate Market Size, 2017-2028
6.4.5 Mexico Antibody Drug Conjugate Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antibody Drug Conjugate Revenue, 2017-2028
6.5.2 By Country - Europe Antibody Drug Conjugate Sales, 2017-2028
6.5.3 Germany Antibody Drug Conjugate Market Size, 2017-2028
6.5.4 France Antibody Drug Conjugate Market Size, 2017-2028
6.5.5 U.K. Antibody Drug Conjugate Market Size, 2017-2028
6.5.6 Italy Antibody Drug Conjugate Market Size, 2017-2028
6.5.7 Russia Antibody Drug Conjugate Market Size, 2017-2028
6.5.8 Nordic Countries Antibody Drug Conjugate Market Size, 2017-2028
6.5.9 Benelux Antibody Drug Conjugate Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antibody Drug Conjugate Revenue, 2017-2028
6.6.2 By Region - Asia Antibody Drug Conjugate Sales, 2017-2028
6.6.3 China Antibody Drug Conjugate Market Size, 2017-2028
6.6.4 Japan Antibody Drug Conjugate Market Size, 2017-2028
6.6.5 South Korea Antibody Drug Conjugate Market Size, 2017-2028
6.6.6 Southeast Asia Antibody Drug Conjugate Market Size, 2017-2028
6.6.7 India Antibody Drug Conjugate Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antibody Drug Conjugate Revenue, 2017-2028
6.7.2 By Country - South America Antibody Drug Conjugate Sales, 2017-2028
6.7.3 Brazil Antibody Drug Conjugate Market Size, 2017-2028
6.7.4 Argentina Antibody Drug Conjugate Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antibody Drug Conjugate Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antibody Drug Conjugate Sales, 2017-2028
6.8.3 Turkey Antibody Drug Conjugate Market Size, 2017-2028
6.8.4 Israel Antibody Drug Conjugate Market Size, 2017-2028
6.8.5 Saudi Arabia Antibody Drug Conjugate Market Size, 2017-2028
6.8.6 UAE Antibody Drug Conjugate Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Seattle Genetics/Takeda
7.1.1 Seattle Genetics/Takeda Corporate Summary
7.1.2 Seattle Genetics/Takeda Business Overview
7.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Major Product Offerings
7.1.4 Seattle Genetics/Takeda Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.1.5 Seattle Genetics/Takeda Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Antibody Drug Conjugate Major Product Offerings
7.2.4 Roche Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.2.5 Roche Key News
7.3 ImmunoGen
7.3.1 ImmunoGen Corporate Summary
7.3.2 ImmunoGen Business Overview
7.3.3 ImmunoGen Antibody Drug Conjugate Major Product Offerings
7.3.4 ImmunoGen Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.3.5 ImmunoGen Key News
7.4 Immunomedics
7.4.1 Immunomedics Corporate Summary
7.4.2 Immunomedics Business Overview
7.4.3 Immunomedics Antibody Drug Conjugate Major Product Offerings
7.4.4 Immunomedics Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.4.5 Immunomedics Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Antibody Drug Conjugate Major Product Offerings
7.5.4 Pfizer Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Celldex Therapeutics
7.6.1 Celldex Therapeutics Corporate Summary
7.6.2 Celldex Therapeutics Business Overview
7.6.3 Celldex Therapeutics Antibody Drug Conjugate Major Product Offerings
7.6.4 Celldex Therapeutics Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.6.5 Celldex Therapeutics Key News
7.7 Millennium Pharmaceuticals
7.7.1 Millennium Pharmaceuticals Corporate Summary
7.7.2 Millennium Pharmaceuticals Business Overview
7.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Major Product Offerings
7.7.4 Millennium Pharmaceuticals Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.7.5 Millennium Pharmaceuticals Key News
7.8 Bayer HealthCare
7.8.1 Bayer HealthCare Corporate Summary
7.8.2 Bayer HealthCare Business Overview
7.8.3 Bayer HealthCare Antibody Drug Conjugate Major Product Offerings
7.8.4 Bayer HealthCare Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.8.5 Bayer HealthCare Key News
7.9 Mersana Therapeutics
7.9.1 Mersana Therapeutics Corporate Summary
7.9.2 Mersana Therapeutics Business Overview
7.9.3 Mersana Therapeutics Antibody Drug Conjugate Major Product Offerings
7.9.4 Mersana Therapeutics Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.9.5 Mersana Therapeutics Key News
7.10 Heidelberg Pharma
7.10.1 Heidelberg Pharma Corporate Summary
7.10.2 Heidelberg Pharma Business Overview
7.10.3 Heidelberg Pharma Antibody Drug Conjugate Major Product Offerings
7.10.4 Heidelberg Pharma Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.10.5 Heidelberg Pharma Key News
7.11 Oxford BioTherapeutics
7.11.1 Oxford BioTherapeutics Corporate Summary
7.11.2 Oxford BioTherapeutics Antibody Drug Conjugate Business Overview
7.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Major Product Offerings
7.11.4 Oxford BioTherapeutics Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.11.5 Oxford BioTherapeutics Key News
7.12 Takeda Pharmaceutical Company Limited
7.12.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.12.2 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Business Overview
7.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Major Product Offerings
7.12.4 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales and Revenue in Global (2017-2022)
7.12.5 Takeda Pharmaceutical Company Limited Key News
8 GLOBAL ANTIBODY DRUG CONJUGATE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antibody Drug Conjugate Production Capacity, 2017-2028
8.2 Antibody Drug Conjugate Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibody Drug Conjugate Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIBODY DRUG CONJUGATE SUPPLY CHAIN ANALYSIS
10.1 Antibody Drug Conjugate Industry Value Chain
10.2 Antibody Drug Conjugate Upstream Market
10.3 Antibody Drug Conjugate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antibody Drug Conjugate Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Antibody Drug Conjugate in Global Market
Table 2. Top Antibody Drug Conjugate Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antibody Drug Conjugate Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antibody Drug Conjugate Revenue Share by Companies, 2017-2022
Table 5. Global Antibody Drug Conjugate Sales by Companies, (K Units), 2017-2022
Table 6. Global Antibody Drug Conjugate Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antibody Drug Conjugate Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Antibody Drug Conjugate Product Type
Table 9. List of Global Tier 1 Antibody Drug Conjugate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody Drug Conjugate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antibody Drug Conjugate Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antibody Drug Conjugate Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antibody Drug Conjugate Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antibody Drug Conjugate Sales (K Units), 2017-2022
Table 15. By Type - Global Antibody Drug Conjugate Sales (K Units), 2023-2028
Table 16. By Application – Global Antibody Drug Conjugate Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antibody Drug Conjugate Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antibody Drug Conjugate Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antibody Drug Conjugate Sales (K Units), 2017-2022
Table 20. By Application - Global Antibody Drug Conjugate Sales (K Units), 2023-2028
Table 21. By Region – Global Antibody Drug Conjugate Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antibody Drug Conjugate Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antibody Drug Conjugate Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antibody Drug Conjugate Sales (K Units), 2017-2022
Table 25. By Region - Global Antibody Drug Conjugate Sales (K Units), 2023-2028
Table 26. By Country - North America Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 29. By Country - North America Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 30. By Country - Europe Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 33. By Country - Europe Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 34. By Region - Asia Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 37. By Region - Asia Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 38. By Country - South America Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 41. By Country - South America Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 46. Seattle Genetics/Takeda Corporate Summary
Table 47. Seattle Genetics/Takeda Antibody Drug Conjugate Product Offerings
Table 48. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Roche Corporate Summary
Table 50. Roche Antibody Drug Conjugate Product Offerings
Table 51. Roche Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. ImmunoGen Corporate Summary
Table 53. ImmunoGen Antibody Drug Conjugate Product Offerings
Table 54. ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Immunomedics Corporate Summary
Table 56. Immunomedics Antibody Drug Conjugate Product Offerings
Table 57. Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Antibody Drug Conjugate Product Offerings
Table 60. Pfizer Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Celldex Therapeutics Corporate Summary
Table 62. Celldex Therapeutics Antibody Drug Conjugate Product Offerings
Table 63. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Millennium Pharmaceuticals Corporate Summary
Table 65. Millennium Pharmaceuticals Antibody Drug Conjugate Product Offerings
Table 66. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Bayer HealthCare Corporate Summary
Table 68. Bayer HealthCare Antibody Drug Conjugate Product Offerings
Table 69. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Mersana Therapeutics Corporate Summary
Table 71. Mersana Therapeutics Antibody Drug Conjugate Product Offerings
Table 72. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Heidelberg Pharma Corporate Summary
Table 74. Heidelberg Pharma Antibody Drug Conjugate Product Offerings
Table 75. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Oxford BioTherapeutics Corporate Summary
Table 77. Oxford BioTherapeutics Antibody Drug Conjugate Product Offerings
Table 78. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Takeda Pharmaceutical Company Limited Corporate Summary
Table 80. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Offerings
Table 81. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Antibody Drug Conjugate Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Antibody Drug Conjugate Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Antibody Drug Conjugate Production by Region, 2017-2022 (K Units)
Table 85. Global Antibody Drug Conjugate Production by Region, 2023-2028 (K Units)
Table 86. Antibody Drug Conjugate Market Opportunities & Trends in Global Market
Table 87. Antibody Drug Conjugate Market Drivers in Global Market
Table 88. Antibody Drug Conjugate Market Restraints in Global Market
Table 89. Antibody Drug Conjugate Raw Materials
Table 90. Antibody Drug Conjugate Raw Materials Suppliers in Global Market
Table 91. Typical Antibody Drug Conjugate Downstream
Table 92. Antibody Drug Conjugate Downstream Clients in Global Market
Table 93. Antibody Drug Conjugate Distributors and Sales Agents in Global Market
Table 1. Key Players of Antibody Drug Conjugate in Global Market
Table 2. Top Antibody Drug Conjugate Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antibody Drug Conjugate Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antibody Drug Conjugate Revenue Share by Companies, 2017-2022
Table 5. Global Antibody Drug Conjugate Sales by Companies, (K Units), 2017-2022
Table 6. Global Antibody Drug Conjugate Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antibody Drug Conjugate Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Antibody Drug Conjugate Product Type
Table 9. List of Global Tier 1 Antibody Drug Conjugate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody Drug Conjugate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antibody Drug Conjugate Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antibody Drug Conjugate Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antibody Drug Conjugate Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antibody Drug Conjugate Sales (K Units), 2017-2022
Table 15. By Type - Global Antibody Drug Conjugate Sales (K Units), 2023-2028
Table 16. By Application – Global Antibody Drug Conjugate Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antibody Drug Conjugate Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antibody Drug Conjugate Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antibody Drug Conjugate Sales (K Units), 2017-2022
Table 20. By Application - Global Antibody Drug Conjugate Sales (K Units), 2023-2028
Table 21. By Region – Global Antibody Drug Conjugate Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antibody Drug Conjugate Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antibody Drug Conjugate Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antibody Drug Conjugate Sales (K Units), 2017-2022
Table 25. By Region - Global Antibody Drug Conjugate Sales (K Units), 2023-2028
Table 26. By Country - North America Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 29. By Country - North America Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 30. By Country - Europe Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 33. By Country - Europe Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 34. By Region - Asia Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 37. By Region - Asia Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 38. By Country - South America Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 41. By Country - South America Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antibody Drug Conjugate Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antibody Drug Conjugate Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Antibody Drug Conjugate Sales, (K Units), 2023-2028
Table 46. Seattle Genetics/Takeda Corporate Summary
Table 47. Seattle Genetics/Takeda Antibody Drug Conjugate Product Offerings
Table 48. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Roche Corporate Summary
Table 50. Roche Antibody Drug Conjugate Product Offerings
Table 51. Roche Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. ImmunoGen Corporate Summary
Table 53. ImmunoGen Antibody Drug Conjugate Product Offerings
Table 54. ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Immunomedics Corporate Summary
Table 56. Immunomedics Antibody Drug Conjugate Product Offerings
Table 57. Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Antibody Drug Conjugate Product Offerings
Table 60. Pfizer Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Celldex Therapeutics Corporate Summary
Table 62. Celldex Therapeutics Antibody Drug Conjugate Product Offerings
Table 63. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Millennium Pharmaceuticals Corporate Summary
Table 65. Millennium Pharmaceuticals Antibody Drug Conjugate Product Offerings
Table 66. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Bayer HealthCare Corporate Summary
Table 68. Bayer HealthCare Antibody Drug Conjugate Product Offerings
Table 69. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Mersana Therapeutics Corporate Summary
Table 71. Mersana Therapeutics Antibody Drug Conjugate Product Offerings
Table 72. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Heidelberg Pharma Corporate Summary
Table 74. Heidelberg Pharma Antibody Drug Conjugate Product Offerings
Table 75. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Oxford BioTherapeutics Corporate Summary
Table 77. Oxford BioTherapeutics Antibody Drug Conjugate Product Offerings
Table 78. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Takeda Pharmaceutical Company Limited Corporate Summary
Table 80. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Offerings
Table 81. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Antibody Drug Conjugate Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Antibody Drug Conjugate Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Antibody Drug Conjugate Production by Region, 2017-2022 (K Units)
Table 85. Global Antibody Drug Conjugate Production by Region, 2023-2028 (K Units)
Table 86. Antibody Drug Conjugate Market Opportunities & Trends in Global Market
Table 87. Antibody Drug Conjugate Market Drivers in Global Market
Table 88. Antibody Drug Conjugate Market Restraints in Global Market
Table 89. Antibody Drug Conjugate Raw Materials
Table 90. Antibody Drug Conjugate Raw Materials Suppliers in Global Market
Table 91. Typical Antibody Drug Conjugate Downstream
Table 92. Antibody Drug Conjugate Downstream Clients in Global Market
Table 93. Antibody Drug Conjugate Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Antibody Drug Conjugate Segment by Type
Figure 2. Antibody Drug Conjugate Segment by Application
Figure 3. Global Antibody Drug Conjugate Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antibody Drug Conjugate Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antibody Drug Conjugate Revenue, 2017-2028 (US$, Mn)
Figure 7. Antibody Drug Conjugate Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antibody Drug Conjugate Revenue in 2021
Figure 9. By Type - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 10. By Type - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antibody Drug Conjugate Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 13. By Application - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antibody Drug Conjugate Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 16. By Region - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 19. US Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 24. Germany Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 25. France Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 33. China Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 37. India Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 40. Brazil Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 44. Turkey Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antibody Drug Conjugate Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Antibody Drug Conjugate by Region, 2021 VS 2028
Figure 50. Antibody Drug Conjugate Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Antibody Drug Conjugate Segment by Type
Figure 2. Antibody Drug Conjugate Segment by Application
Figure 3. Global Antibody Drug Conjugate Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antibody Drug Conjugate Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antibody Drug Conjugate Revenue, 2017-2028 (US$, Mn)
Figure 7. Antibody Drug Conjugate Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antibody Drug Conjugate Revenue in 2021
Figure 9. By Type - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 10. By Type - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antibody Drug Conjugate Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 13. By Application - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antibody Drug Conjugate Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 16. By Region - Global Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 19. US Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 24. Germany Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 25. France Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 33. China Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 37. India Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 40. Brazil Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antibody Drug Conjugate Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antibody Drug Conjugate Sales Market Share, 2017-2028
Figure 44. Turkey Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antibody Drug Conjugate Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antibody Drug Conjugate Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Antibody Drug Conjugate by Region, 2021 VS 2028
Figure 50. Antibody Drug Conjugate Industry Value Chain
Figure 51. Marketing Channels
